Global Hypodermic Needles Market Research, 2030
The global global hypodermic needles market was valued at $3.3 billion in 2020, and is projected to reach $4.5 billion by 2030, growing at a CAGR of 3.4% from 2020 to 2030.
A hypodermic needle is a hollow needle widely used across medical settings to carry out different applications, such as drug delivery, vaccination, and blood specimen collection. These needles function through two different mechanisms, namely safety and non-safety needles. They are used to administer and inject drugs in the body and also to withdraw fluids from the body for examination and research purposes.
Needlestick injuries have significant impact on the hypodermic needles market size, which is projected to further increase during the forecast period. Needlestick injuries are the leading cause of blood-borne disease among healthcare professionals. The increase in prevalence of chronic infectious diseases such as Hepatitis B and Hepatitis C, drives the growth of hypodermic needles industry. according to World Health Organization, it was estimated that 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year in 2019., Hepatitis B resulted in an estimated 820, 000 deaths, and hundreds of thousands of health care workers were at high risk of work-related infections, such as hepatitis B, hepatitis C, and HIV due to exposure to contaminated needle sticks and sharp injuries. Furthermore, during vaccination, hypodermic needles are used to deliver vaccines to patients. According to World Health Organization, as of 17 April 2022, a total of 11,324,805,837 COVID-19 vaccine doses have been administered globally, which is expected to increase the demand of hypodermic needles industry.
Rise in incidence of chronic & lifestyle diseases, especially increase in prevalence of diabetes globally, technological advancements in the hypodermic needles market, and increase in demand for advanced hypodermic needles solutions are expected to drive the market growth. However, availability of alternative modes of drug delivery, low awareness towards safety syringes, and high cost of hypodermic needles hamper the market growth. The upsurge in demand for hypodermic needles, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for hypodermic needles market forecast .
Furthermore, technological development in the pharmaceutical industry to manufacture safe hypodermic needles is expected to provide remunerative opportunities for expansion of the global hypodermic needles market size during the forecast period. Moreover, presence of key manufacturing companies to manufacture and distribute hypodermic needles and rise in expenditure on healthcare products propel hypodermic needles market growth.
The incidence of chronic & lifestyle diseases, especially diabetes is on the rise. According to the World Health Organization, about 422 million people globally had diabetes in 2014, with the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. Both, the number of cases and the prevalence of diabetes are steadily increasing over the past few decades. Therefore, rise in prevalence of needlestick injuries and diabetes is expected to lead to growth of hypodermic needles market.
The global hypodermic needles market analysis is segmented into Products, Application and End Users and region. By product, the market is segmented into safety hypodermic needles and non-safety hypodermic needles.
By product type, the market is bifurcated into safety and non-safety hypodermic needles. The safety hypodermic needles segment is sub-segmented on the basis of type and mode of activation. Based on type, safety hypodermic needles are divided into retractable and nonretractable needles. By mode of activation, they are classified into active and passive hypodermic needles. By application, the market is classified as drug delivery, vaccination, and blood specimen collection. By end user, the market is segment into hospitals, diabetic patient, family practitioner, psychiatry, and others.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segmental review
Depending on product type, the safety hypodermic needles segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to advancements in R&D activities in the healthcare sector and increase in prevalence of the needlestick injury. Safety hypodermic needles are widely preferred over non-safety hypodermic needles owing to the convenience and safety offered by these products. Safety hypodermic needles have advanced features such as luer lock, single-handed technique, and other safety features.
Depending on application, the drug delivery segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to advancement in the healthcare sector and because of less wastage of drugs, shorter onset time. The drug delivery segment is widely preferred over other segments owing to the convenience and safety offered by these products.
Depending on end user, hospitals were the largest end users of hypodermic needles in 2020, and this trend is expected to continue during the forecast period. Hospitals widely use hypodermic needles for various purposes, such as vaccination, drug delivery, blood specimen collection, and others. Also, hospitals of developed countries have made it mandatory to use hypodermic needles. World Health Organization (WHO) has recommended all healthcare providers to switch over to safer needles to prevent the spread of blood-borne diseases, such as hepatitis, HIV, and viral hemorrhagic fevers.
Asia-Pacific garnered a major hypodermic needles market share in 2020, and is expected to continue to dominate during the forecast period, owing to increase in prevalence of chronic diseases, presence of a high population base (with India and China being the most populated countries), presence of unmet medical needs, and increase in disposable incomes of people, and rise in awareness about the use of hypodermic needles in the region.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global hypodermic needles market analysis from 2020 to 2030 to identify the prevailing global hypodermic needles market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the global hypodermic needles market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global global hypodermic needles market trends, key players, market segments, application areas, and market growth strategies.
Global Hypodermic Needles Market Report Highlights
| Aspects | Details |
 By Products |
|
 By Application |
|
 By End Users |
|
 By Region |
|
 Key Market Players | Cardinal Health Inc., B. BRAUN MELSUNGEN AG, McKesson Corporation, Becton, Dickinson and Company, Retractable Technologies, Inc., TERUMO MEDICAL CORPORATION, EXELINT INTERNATIONAL CO., Nipro Corporation, Hitech Syringes, CONNECTICUT HYPODERMICS INC. |
Analyst Review
Hypodermic needles are expected to witness high adoption rate owing to increase in number of needlestick- and sharps-related injuries. The hypodermic needles market shows high growth potential in the healthcare industry owing to the increase in usage of injectable drugs & vaccines, active initiatives undertaken both by governments & nongovernmental organizations, especially the World Health Organization (WHO), and surge in applications of injection & infusion therapies. In addition, technological advancements such as improved retractable & passive safety hypodermic needles drive the growth of the industry. Asia-Pacific and LAMEA are expected to offer lucrative growth opportunities to the key players operating in the market.
Rise in demand for safety injection devices has increased the need for innovative technologies and newer versions of safety hypodermic needles incorporating advanced mechanisms such as automatic needle retraction and barrel lock mechanism, which boost the market growth.
However, alternative modes of drug delivery and high costs associated with safety hypodermic needles restrain the market growth. Curently, the safety hypodermic needles segment is the largest revenue contributor to the global hypodermic needles market. The use of hypodermic needles is mandated across different hospitals and health centers and other healthcare settings, as they greatly reduce the incidence of needlestick injuries. This factor along with increase in demand for infusion & injection therapies augment the growth of the market. In addition, hypodermic needle manufacturers and distributors focus on expanding their presence in the emerging economies to strengthen their foothold in the marten. Rapid growth was observed in the shipments of these devices by key manufacturers to improve healthcare services in emerging nations. This trend is expected to offset the challenging conditions in mature markets, such as North America and Europe.
The total market value of hypodermic needles market is $3256 million in 2020.
The forecast period in the report is from 2021 to 2030.
The market value of hypodermic needles market in 2021 was $5202.11 million
The top companies that hold the market share in hypodermic needles market are Becton, Dickinson and Company, B. Braun Melsungen Ag, Cardinal Health Inc., Connecticut Hypodermics Inc., Exelint International Co., Mckesson Corporation, Hi-tech syringes, Retractable Technologies, Inc., Nipro Corporation, and Terumo Medical Corporation.
The base year for the report is 2020.
Loading Table Of Content...
